Fuller v. Colgate-Palmolive Company

District Court, S.D. New York·Decided February 24, 2025·No. 1:24-cv-04225·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

KELLIE ANN FULLER,

Plaintiff, No. 24-CV-4225 (RA) v. MEMORANDUM COLGATE-PALMOLIVE COMPANY, OPINION & ORDER Defendant.

RONNIE ABRAMS, United States District Judge: Plaintiff Kellie Ann Fuller brings this product liability action against Defendant Colgate- Palmolive Company, asserting claims of strict liability, negligence, breach of implied warranty of fitness, and breach of implied warranty of merchantability. Now before this Court is Defendant’s motion to dismiss for failure to state a claim. See Def.’s Mot. to Dismiss, ECF No. 14 (“Mot. to Dismiss”). For the reasons that follow, Defendant’s motion is granted. BACKGROUND For more than ten years, Plaintiff, a resident and citizen of Ohio, purchased Fabuloso Multi-Purpose Cleaners to clean her home and hair salon. Compl. ¶¶ 1–2, 10–11, ECF No. 1 (“Compl.”).1 Defendant, a Delaware corporation with its principal place of business in New York, “formulates, manufactures, produces, markets, promotes, warrants, distributes and sells” these cleaning products. Id. ¶¶ 13–14. In May of 2022, Plaintiff developed flu-like symptoms. Id. ¶¶ 2, 21. Although she recovered, her improvement was short-lived. Id. ¶¶ 2–3, 21–22. Within a few days of her

1 The Court draws the following facts from the Complaint, accepting well-pleaded factual allegations as true for purposes of deciding this motion to dismiss. Lynch v. City of New York, 952 F.3d 67, 74–75 (2d Cir. 2020). recovery, Plaintiff’s health markedly declined and, on June 1, 2022, Plaintiff was admitted to the hospital, where she was diagnosed with a pseudomonas aeruginosa infection in her lungs. Id. ¶¶ 3, 22. Plaintiff continued to experience symptoms of and require treatment for her infection through September 2022. Id. On February 8, 2023, Defendant recalled approximately 4.9 million Fabuloso Multi-

Purpose Cleaners due to contamination with bacteria—including pseudomonas aeruginosa and pseudomonas fluorescens—resulting from failure to add the “intended levels” of preservatives to the cleaning products during manufacturing. Id. ¶¶ 4, 6, 23, 25. The recall notice did not apply to “any product purchased before December 16, 2022.” Compl. Ex. B., at 15. Plaintiff alleges that her injuries, which occurred several months prior to Defendant’s sale of products subject to the recall notice, resulted from use of Defendant’s contaminated cleaning products. In particular, she alleges that her injuries were the direct and proximate result of Defendant’s “intentional concealment of such contamination, their failure to warn consumers of such contamination and their failure to timely remove a product with such contamination from

the stream of commerce.” Id. ¶¶ 30–31. Defendant has moved to dismiss the Complaint for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6), which Plaintiff opposes. See Pl.’s Opp’n, ECF No. 17 (“Opp’n”). LEGAL STANDARD To survive a motion to dismiss brought pursuant to Rule 12(b)(6), a complaint must plead “enough facts to state a claim to relief that is plausible on its face.”2 Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the

2 Unless otherwise indicated, case quotations omit all internal citations, quotation marks, footnotes, omissions, and alterations. misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). “Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Id. In deciding a motion to dismiss, the Court “constru[es] the complaint liberally, accepting all factual allegations in the complaint as true, and drawing all reasonable inferences in the plaintiff’s favor,” Vaughn v. Phoenix House N.Y. Inc., 957 F.3d 141, 145 (2d Cir. 2020) (quoting Chambers

v. Time Warner, Inc., 282 F.3d 147, 152 (2d Cir. 2002)), although this “tenet . . . is inapplicable to legal conclusions,” Iqbal, 556 U.S. at 678. DISCUSSION I. Choice of Law

The Court finds, and the parties agree, that Ohio law governs this federal diversity tort action. See Mot. to Dismiss 4; Opp’n 7. “In diversity jurisdiction cases such as this, it is well settled that a federal court must look to the choice of law rules of the forum state.” Curley v. AMR Corp., 153 F.3d 5, 12 (2d Cir. 1998). “In tort actions, if there is a conflict of laws, New York courts apply an interests analysis, under which the law of the jurisdiction having the greatest interest in the litigation is applied.” Id. (quoting AroChem Int’l, Inc. v. Buirkle, 968 F.2d 266, 270 (2d Cir. 1992)). Applying the choice of law rules of New York, the Court concludes that the laws of Ohio, the situs of Plaintiff’s injury, decide this action. See Satterfield v. Maldonado, 127 F. Supp. 3d 177, 189 n.11 (S.D.N.Y. 2015) (“Where the parties are domiciled in different states, the locus of the tort will

almost always be determinative in cases involving conduct-regulating laws.” (quoting Krock v. Lipsay, 97 F.3d 640, 646 (2d Cir. 1996))). II. Analysis of Claims

Plaintiff brings common law claims against Defendant for strict liability, negligence, breach of implied warranty of fitness for a particular purpose, and breach of implied warranty of merchantability. See Compl. ¶¶ 32–57. In its motion to dismiss, Defendant argued that dismissal of Plaintiff’s strict liability and negligence claims is warranted because Plaintiff has failed to plausibly plead that Defendant’s products were the proximate cause of her injuries. Mot. to Dismiss 5. As to her third and fourth causes of action, Defendant argued, and Plaintiff conceded,

that the Ohio Product Liability Act (“OPLA”) abrogates her claims for breach of implied warranty. See id. 5–6; Opp’n 12. On January 28, 2025, the Court ordered the parties to submit supplemental briefing as to whether the OPLA abrogates all product liability claims, including Plaintiff’s strict liability and negligence claims. Order, ECF No. 21. The parties agreed that it does. See Def.’s Letter 1, ECF No. 23; Pl.’s Letter 1, ECF No. 24. The Court finds that the OPLA—which the parties agree “abrogated all common law claims relating to product liability causes of action”—abrogates all four of Plaintiff’s common law product liability claims. Parker v. ACE Hardware Corp., 104 N.E.3d 298, 304 (Ohio Ct.

App. 2018) (quoting Evans v. Hanger Prosthetics & Orthotics, Inc., 735 F. Supp. 2d 785, 795 (N.D. Ohio 2010)); see also Wimbush v. Wyeth, 619 F.3d 632, 637, 639 (6th Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Fuller v. Colgate-Palmolive Company, (S.D.N.Y. 2025).

Fuller v. Colgate-Palmolive Company (Fuller v. Colgate-Palmolive Company) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

City of Sherrill v. Oneida Indian Nation of NY
544 U.S. 197 (Supreme Court, 2005)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Wimbush Ex Rel. Estate of Buchanan v. Wyeth
619 F.3d 632 (Sixth Circuit, 2010)
Krock v. Lipsay
97 F.3d 640 (Second Circuit, 1996)
Evans v. Hanger Prosthetics & Orthotics, Inc.
735 F. Supp. 2d 785 (N.D. Ohio, 2010)
Delahunt v. Cytodyne Technologies
241 F. Supp. 2d 827 (S.D. Ohio, 2003)
Lynch v. City of New York
952 F.3d 67 (Second Circuit, 2020)
Vaughn v. Phoenix House New York
957 F.3d 141 (Second Circuit, 2020)
Curley v. AMR Corp.
153 F.3d 5 (Second Circuit, 1998)
Chambers v. Time Warner, Inc.
282 F.3d 147 (Second Circuit, 2002)
Satterfield v. Maldonado
127 F. Supp. 3d 177 (S.D. New York, 2015)
Parker v. ACE Hardware Corp.
104 N.E.3d 298 (Court of Appeals of Ohio, Second District, Champaign County, 2018)
Ricciuti v. N.Y.C. Transit Authority
941 F.2d 119 (Second Circuit, 1991)